Historique de carrière de Thomas A. Kramer
Anciens postes connus de Thomas A. Kramer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Broncus Technologies, Inc.
Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Directeur Technique/Scientifique/R&D | 01/01/2002 | 01/01/2006 |
HANSEN MEDICAL, INC. | Directeur Technique/Scientifique/R&D | 01/09/2006 | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Hansen Medical, Inc.
Hansen Medical, Inc. Medical SpecialtiesHealth Technology Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and stable control of catheters and catheter-based technologies. It offers Sensei Robotic Catheter System which allows physicians to instinctively navigate flexible catheters with stability and control in interventional procedures within the atria heart chambers. The company was founded by Frederic H. Moll, Daniel T. Wallace, Marvin J. Slepian, and Robert G. Younge on November 18, 2002 and is headquartered in Redwood City, CA. | Health Technology |
Broncus Technologies, Inc.
Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Health Technology |
- Bourse
- Insiders
- Thomas A. Kramer
- Expérience